124 assets in Fallopian Tube Cancer

Mirvetuximab

Adavosertib

Immunoglobulin G1 [188,412-Bis[4-(Azidomethyl)-L-Phenylalanine]], Anti-(Human Folate Receptor ?) (Human-Mus Musculus Monoclonal Sp8166 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Sp8166 ?-Chain, Dimer, Click Reaction Product With 3-[[[[4-[[N-[4-(11,12-Didehydrodibenz[B,F]Azocin-5(6H)-Yl)-1,4-Dioxobutyl]-L-Valyl-N5-(Aminocarbonyl)-L-Ornithyl]Amino]Phenyl]Methoxy]Carbonyl]Amino]-N,?,?-Trimethyl-L-Phenylalanyl-N-[(1S,2E)-3-Carboxy-1-(1-Methylethyl)-2-Buten-1-Yl]-N,3-Dimethyl-L-Valinamide (1:4)

27T51

ai-061

azd5335

Bl-M17D1

Cirtuvivint

Enoblituzumab

ft536

Itraconazole

lyl797

Monoclonal Antibody Trk-950

Re-Stimulated Tumor-Infiltrating Lymphocytes

Sovilnesib

1-118-Signal regulatory protein ? (human) fusion protein with immunoglobulin G4 [128-proline] (human ?4-chain C region C-terminal fragment), dimer

Alpha-Type-1 Polarized Dendritic Cells

Aspirin

R130

Luveltamab Tazevibulin

Etodolac

Huaier Granule

ft538

Sapanisertib